There are 2789 resources available
Discussion LBA60, 1565MO, 1566MO and 1567MO
Presenter: Petros Grivas
Session: Mini oral session - SARS-CoV-2 and cancer
Resources:
Slides
Webcast
Introduction by the chair
Presenter: Lena Specht
Session: Follicular lymphoma: Is watch and wait still a valid option in 2021?
Resources:
Slides
Webcast
Yes
Presenter: Thomas Lister
Session: Follicular lymphoma: Is watch and wait still a valid option in 2021?
Resources:
Slides
Webcast
No
Presenter: Christian Buske
Session: Follicular lymphoma: Is watch and wait still a valid option in 2021?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Lena Specht
Session: Follicular lymphoma: Is watch and wait still a valid option in 2021?
Resources:
Slides
Webcast
Q&A
Presenter: Lena Specht
Session: Follicular lymphoma: Is watch and wait still a valid option in 2021?
Resources:
Slides
Webcast
1562MO - Effectiveness of COVID-19 vaccination in cancer patients: A nationwide Veterans Affairs study
Presenter: Julie Wu
Session: Mini oral session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
1563MO - CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity
Presenter: Radka Obermannova
Session: Mini oral session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
1564MO - Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers
Presenter: Sabrina Salgia
Session: Mini oral session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
LBA60 - Prospective data of >20,000 hospitalised patients with cancer and COVID-19 derived from the International Severe Acute Respiratory and emerging Infections Consortium WHO Coronavirus Clinical Characterisation Consortium: CCP-CANCER UK
Presenter: Tom Drake
Session: Mini oral session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast